Table 1 Baseline Clinic features according to glycometabolism diagnosis by OGTT

Age, y (median, Q_1–3)

64 (55, 73)

61 (52,72)

58 (49, 69))

<0.001

Male, n (%)

711(58.3)

501 (64.5%)

616 (67.7)

<0.001

Tobacco use, n (%)

0.036

 Never

712 (58.4)

428 (55.1)

480 (52.7)

 Quit

110 (9.0)

74 (9.5)

79 (8.7)

 Current

351 (28.8)

246 (31.7)

320 (35.2)

Alcohol consumption, n (%)

0.164

 Mild

213 (17.5)

132 (17.0)

171 (18.8)

 Moderate to severe

165 (13.5)

131 (16.9)

152 (16.7)

 Never

817 (67.0)

494 (63.6)

564 (62.0)

BMI, kg/m² (median, Q_1–3)

25.0 (22.9,27.3)

24.5 (22.5,26.8)

24.2 (22.0,26.2)

<0.001

NIHSS (median,Q₁-Q₃)

5 (2–9)

5 (2,9)

4 (2–8)

0.002

Creatinine,m mol L⁻¹ (median, Q_1–3)

71.2 (58.0, 87.0)

72.0 (60.0, 87.0)

71.8 (59.9, 86.7)

0.425

LDL, m mol L⁻¹ (median, Q_1–3)

3.0 (2.4, 3.6)

2.9 (2.3, 3.5)

2.8 (2.3, 3.4)

0.001

HDL,m mol L⁻¹(median, Q_1–3)

1.1(1.0, 1.3)

1.2 (1.0, 1.4)

1.2 (1.1, 1.4)

<0.001

Systolic blood pressure, mmHg (median, Q_1–3)

150 (138, 160)

143 (130, 160)

146 (130, 160)

<0.001

Homocysteine, μ mol L⁻¹, (median, Q_1–3)

14.4 (11.5, 18.7)

15.5 (12.0, 21.9)

15.7 (12.3, 22.8)

<0.001

HOMA2-IR (median, Q_1–3)

2.5 (1.6, 4.0)

1.9 (1.1, 3.0)

1.6 (0.9, 2.5)

<0.001

Past medical history, yes, n (%)

 Coronary artery disease

172 (14.1)

87 (11.2)

90 (9.9)

0.009

 Hypertension

795 (65.2)

470 (60.5)

514 (56.5)

<0.001

 Atrial fibrillation

66 (5.4)

54 (6.9)

31 (3.4)

0.006

Stroke types, n (%)

<0.001

 IS

1015 (83.2)

541 (69.6)

675 (74.2)

 ICH

174 (14.3)

185 (23.8)

198 (21.8)

 SAH

31 (2.5)

51 (6.6)

37 (4.1)